• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶去kringle结构域衍生物的纤维蛋白溶解作用及其受血浆蛋白酶抑制剂的调节

Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors.

作者信息

Komorowicz E, Kolev K, Machovich R

机构信息

Department of Medical Biochemistry, Semmelweis University of Medicine, Budapest, Hungary.

出版信息

Biochemistry. 1998 Jun 23;37(25):9112-8. doi: 10.1021/bi980180d.

DOI:10.1021/bi980180d
PMID:9636057
Abstract

Quantitative characterization of the interaction of des-kringle1-5-plasmin (microplasmin) with fibrin(ogen) and plasma protease inhibitors may serve as a tool for further evaluation of the role of kringle domains in the regulation of fibrinolysis. Comparison of fibrin(ogen) degradation products yielded by plasmin, miniplasmin (des-kringle1-4-plasmin), microplasmin, and trypsin on SDS gel electrophoresis indicates that the differences in the enzyme structure result in different rates of product formation, whereas the products of the four proteases are very similar in molecular weight. Kinetic parameters show that plasmin is the most efficient enzyme in fibrinogen degradation, and the kcat/KM ratio decreases in parallel with the loss of the kringle domains. The catalytic sites of the four proteases have similar affinities for fibrin (KM values between 0.12 and 0.21 microM). Trypsin has the highest catalytic constant for fibrin digestion (kcat = 0.47 s-1), and among plasmins with different kringle structures, the loss of kringle5 results in a markedly lower catalytic rate constant (kcat = 0.0076 s-1 for microplasmin vs 0.048 s-1 for miniplasmin and 0.064 s-1 for plasmin). In addition, microplasmin is inactivated by plasmin inhibitor (k" = 3.9 x 10(5) M-1 s-1) and antithrombin (k" = 1.4 x 10(3) M-1 s-1) and the rate of inactivation decreases in the presence of fibrin(ogen). Heparin (250 nM) accelerates the inactivation of microplasmin by antithrombin (k" = 10.5 x 10(3) M-1 s-1 ), whereas that by plasmin inhibitor is not affected (k" = 4.2 x 10(5) M-1 s-1).

摘要

去kringle1-5-纤溶酶(微纤溶酶)与纤维蛋白(原)及血浆蛋白酶抑制剂相互作用的定量表征,可作为进一步评估kringle结构域在纤维蛋白溶解调节中作用的工具。纤溶酶、微型纤溶酶(去kringle1-4-纤溶酶)、微纤溶酶和胰蛋白酶在SDS凝胶电泳上产生的纤维蛋白(原)降解产物的比较表明,酶结构的差异导致产物形成速率不同,而这四种蛋白酶的产物分子量非常相似。动力学参数表明,纤溶酶是纤维蛋白原降解中最有效的酶,且kcat/KM比值随kringle结构域的缺失而平行下降。这四种蛋白酶的催化位点对纤维蛋白具有相似的亲和力(KM值在0.12至0.21微摩尔之间)。胰蛋白酶对纤维蛋白消化具有最高的催化常数(kcat = 0.47 s-1),在具有不同kringle结构的纤溶酶中,kringle5的缺失导致催化速率常数显著降低(微纤溶酶的kcat = 0.0076 s-1,微型纤溶酶为0.048 s-1,纤溶酶为0.064 s-1)。此外,微纤溶酶被纤溶酶抑制剂(k" = 3.9 x 10(5) M-1 s-1)和抗凝血酶(k" = 1.4 x 10(3) M-1 s-1)灭活,且在有纤维蛋白(原)存在时灭活速率降低。肝素(250 nM)加速抗凝血酶对微纤溶酶的灭活(k" = 10.5 x 10(3) M-1 s-1),而对纤溶酶抑制剂的灭活无影响(k" = 4.2 x 10(5) M-1 s-1)。

相似文献

1
Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors.纤溶酶去kringle结构域衍生物的纤维蛋白溶解作用及其受血浆蛋白酶抑制剂的调节
Biochemistry. 1998 Jun 23;37(25):9112-8. doi: 10.1021/bi980180d.
2
Functional evaluation of the structural features of proteases and their substrate in fibrin surface degradation.蛋白酶及其底物在纤维蛋白表面降解中的结构特征功能评估。
J Biol Chem. 1997 May 23;272(21):13666-75. doi: 10.1074/jbc.272.21.13666.
3
Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors.在血浆蛋白酶抑制剂存在的情况下,肝素对纤溶酶、微型纤溶酶和中性粒细胞弹性蛋白酶纤溶活性的调节作用。
Blood Coagul Fibrinolysis. 1994 Dec;5(6):905-11. doi: 10.1097/00001721-199412000-00006.
4
Quantitative comparison of fibrin degradation with plasmin, miniplasmin, neurophil leukocyte elastase and cathepsin G.纤维蛋白与纤溶酶、微型纤溶酶、中性粒细胞弹性蛋白酶及组织蛋白酶G的降解定量比较
Thromb Haemost. 1996 Jan;75(1):140-6.
5
[Hydrolysis of polymeric fibrin by plasmin, miniplasmin, microplasmin and trypsin].[纤溶酶、微型纤溶酶、微纤溶酶和胰蛋白酶对聚合纤维蛋白的水解作用]
Ukr Biokhim Zh (1978). 1992 May-Jun;64(3):14-20.
6
[Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].[纤溶酶介导的纤维蛋白溶解动力学:纤维蛋白降解产物的抑制作用]
Bioorg Khim. 1996 Dec;22(12):911-5.
7
Proteolytic resistance conferred to fibrinogen by von Willebrand factor.von Willebrand 因子赋予纤维蛋白原的抗蛋白水解作用。
Thromb Haemost. 2010 Feb;103(2):291-8. doi: 10.1160/TH09-07-0420. Epub 2009 Dec 18.
8
Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.α-N-乙酰-L-赖氨酸甲酯、ε-氨基己酸和氨甲环酸的抗纤维蛋白溶解活性。kringle相互作用和活性位点抑制的重要性。
Arterioscler Thromb. 1992 Jun;12(6):708-16. doi: 10.1161/01.atv.12.6.708.
9
Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.纤溶酶原kringle 1和4在纤维蛋白溶解以及纤溶酶诱导的细胞脱离和凋亡中的功能层级
FEBS J. 2005 Jul;272(13):3387-400. doi: 10.1111/j.1742-4658.2005.04754.x.
10
Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding.单个载脂蛋白(a)kringle结构域的抗纤溶作用:与纤维蛋白原结合的关系。
Protein Eng. 2001 Jun;14(6):427-38. doi: 10.1093/protein/14.6.427.

引用本文的文献

1
Kringle-Dependent Inhibition of Plasmin-Mediated Fibrinolysis by Native and Citrullinated Core Histones.天然和瓜氨酸化核心组蛋白通过kringle结构域对纤溶酶介导的纤维蛋白溶解的抑制作用
Int J Mol Sci. 2025 Jun 17;26(12):5799. doi: 10.3390/ijms26125799.
2
The Fibrinolytic System: Mysteries and Opportunities.纤维蛋白溶解系统:谜团与机遇
Hemasphere. 2021 Jun 1;5(6):e570. doi: 10.1097/HS9.0000000000000570. eCollection 2021 Jun.
3
Structure and Function of Trypsin-Loaded Fibrinolytic Liposomes.载胰蛋白酶的纤溶脂质体的结构与功能
Biomed Res Int. 2017;2017:5130495. doi: 10.1155/2017/5130495. Epub 2017 Jul 3.
4
Coagulation factor XIIIa is inactivated by plasmin.凝血因子XIIIa被纤溶酶灭活。
Blood. 2015 Nov 12;126(20):2329-37. doi: 10.1182/blood-2015-07-650713. Epub 2015 Sep 10.
5
Why so little progress in therapeutic thrombolysis? The current state of the art and prospects for improvement.治疗性溶栓为何进展如此缓慢?当前的技术水平及改进前景。
J Thromb Thrombolysis. 2015 Nov;40(4):480-7. doi: 10.1007/s11239-015-1217-3.
6
Purification and characterization of mutant miniPlasmin for thrombolytic therapy.突变型 miniPlasmin 的纯化与表征及其在溶栓治疗中的应用。
Thromb J. 2013 Jan 30;11(1):2. doi: 10.1186/1477-9560-11-2.
7
Mechanical stability and fibrinolytic resistance of clots containing fibrin, DNA, and histones.含有纤维蛋白、DNA 和组蛋白的血栓的机械稳定性和抗纤维蛋白溶解能力。
J Biol Chem. 2013 Mar 8;288(10):6946-56. doi: 10.1074/jbc.M112.404301. Epub 2013 Jan 4.
8
A high affinity interaction of plasminogen with fibrin is not essential for efficient activation by tissue-type plasminogen activator.纤溶酶原与纤维蛋白的高亲和力相互作用对于组织型纤溶酶原激活物的有效激活并非必需。
J Biol Chem. 2012 Feb 10;287(7):4652-61. doi: 10.1074/jbc.M111.317719. Epub 2011 Dec 20.
9
Hindered dissolution of fibrin formed under mechanical stress.在机械应力下形成的纤维蛋白溶解受阻。
J Thromb Haemost. 2011 May;9(5):979-86. doi: 10.1111/j.1538-7836.2011.04203.x.
10
Proteolytic resistance conferred to fibrinogen by von Willebrand factor.von Willebrand 因子赋予纤维蛋白原的抗蛋白水解作用。
Thromb Haemost. 2010 Feb;103(2):291-8. doi: 10.1160/TH09-07-0420. Epub 2009 Dec 18.